Authors:
VONBAHR C
STEINER E
KOIKE Y
GABRIELSSON J
Citation: C. Vonbahr et al., TIME-COURSE OF ENZYME-INDUCTION IN HUMANS - EFFECT OF PENTOBARBITAL ON NORTRIPTYLINE METABOLISM, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 18-26
Citation: B. Beermann et al., FIBRINOLYTIC TREATMENT IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - USEAND RISKS IN CLINICAL-PRACTICE, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 179-182
Authors:
MOVINOSSWALD G
HAMMARLUNDUDENAES M
VONBAHR C
ENEROTH P
WALTONBOWEN K
Citation: G. Movinosswald et al., INFLUENCE OF THE DOSING INTERVAL ON PROLACTIN-RELEASE AFTER REMOXIPRIDE, British journal of clinical pharmacology, 39(5), 1995, pp. 503-510
Authors:
HU Y
MISHIN V
JOHANSSON I
VONBAHR C
CROSS A
RONIS MJJ
BADGER TM
INGELMANSUNDBERG M
Citation: Y. Hu et al., CHLORMETHIAZOLE AS AN EFFICIENT INHIBITOR OF CYTOCHROME-P450 2E1 EXPRESSION IN RAT-LIVER, The Journal of pharmacology and experimental therapeutics, 269(3), 1994, pp. 1286-1291